Heavy Menstrual Bleeding (HMB)

Blood loss that interferes with physical, social, emotional, or material aspect of a woman's life

Aetiology

Causes of heavy menstrual bleeeding

  • Fibroids (20-30%)
    • Benign smooth muscle tumours of the uterus
  • Polyps (5-10%)
  • Adenomyosis (5%)
    • Non-neoplastic endometrial glands and stroma in the myometrium
    • Associated with hyperplasia and hypertrophy of the surrounding myometrium
  • Coagulopathy
    • Most common is von Willebrand disease
    • May be caused by medication
    • Referral to haematology required
  • Malignancy

Risk factors

  • The two main risk factors for heavy menstrual bleeding are age (more likely at menarche and approaching the menopause), and obesity
  • There are also other risk factors that relate to the specific causes of HMB e.g. previous caesarean section as a risk factor for adenomyosis

Clinical presentation

Symptoms

  • Bleeding during menstruation deemed to be excessive for the individual woman
  • Fatigue
  • Shortness of breath (if associated anaemia)

Signs

  • Pallor (anaemia)
  • Palpable uterus or pelvic mass
    • Try to ascertain if the uterus is smooth or irregular (fibroids)
    • A tender uterus or cervical excitation point toward adenomyosis/endometriosis
  • Inflamed cervix/cervical polyp/cervical tumour
  • Vaginal tumour

Investigations

  • Exclude pregnancy
  • Bloods - FBC, coag screen if indicated
  • Cervical smear, swabs for infection
  • Transvaginal US is most clinically useful for assessing the endometrium and ovaries - should be considered if the uterus or a pelvic mass is palpable on examination, or if pharmacological treatment has failed
  • Pipelle endometrial biopsy
    • Indications for biopsy include persistent intermenstrual bleeding, >45 years old, and/or failure of pharmacological treatment
  • Hysteroscopy and endometrial biopsy
    • Typically performed when ultrasound identifies pathology, or is inconclusive

Management

  • 1st line - mirena coil (levonorgestral-releasing intrauterine system, LNG-IUS)
  • 2nd line - transexamic acid, COC
    • Depends on women's wishes for fertility - tranexamic acid taken only during menses to reduce bleeding, no effect on fertility
  • 3rd line - progesterone only (oral norethisterone, depo or implant)
  • 4th line - surgical management/referral to secondary care
    • Surgical management options: polypectomy, endometrial ablation, uterine artery embolosation, myomectomy, hysterectomy